The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC

Cancer Biomarkers

Volumn 16, Issue 1, 2016, Pages 109-115

  Eskandari Nasab, Ebrahim ^a,b   Hashemi, Mohammad ^a,b   Ebrahimi, Mahboubeh ^b   Amininia, Shadi ^b  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Deletion polymorphism; NF kB

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR MARKER;

ALLELE; ARTICLE; BREAST CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CODOMINANCE; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; INDEL MUTATION; INHERITANCE; IRANIAN PEOPLE; MAJOR CLINICAL STUDY; NF KB1 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; BREAST NEOPLASMS; CANCER GRADING; CANCER STAGING; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; ODDS RATIO; RISK; TUMOR VOLUME;

ADULT; ALLELES; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDEL MUTATION; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NF-KAPPA B P50 SUBUNIT; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK; TUMOR BURDEN;

EID: 84956811014     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-150546     Document Type: Article

References (35)

1. Wu JT, Kral JG, The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy, J Surg Res 123 (2005), 158-69.
2. Turashvili G, Bouchal J, Burkadze G, Kolar Z, Differentiation of tumours of ductal and lobular origin: II. Genomics of invasive ductal and lobular breast carcinomas, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149 (2005), 63-8.
3. Harirchi I, Kolahdoozan S, Karbakhsh M, Chegini N, Mohseni SM, Montazeri A, Momtahen AJ, Kashefi A, Ebrahimi M, Twenty years of breast cancer in Iran: downstaging without a formal screening program, Ann Oncol 22 (2011), 93-7.
4. Hashemi M, Fazaeli A, Ghavami S, Eskandari-Nasab E, Arbabi F, Mashhadi MA, Taheri M, Chaabane W, Jain MV, Los MJ, Functional polymorphisms of FAS and FASL gene and risk of breast cancer-pilot study of 134 cases, PLoS One 8 (2013), e53075.
5. Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A, Breast cancer in Iran: a review of 903 case records, Public Health 114 (2000), 143-5.
6. Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, Ebrahimi M, Breast cancer in Iran: an epidemiological review, Breast J 13 (2007), 383-91.
7. Biswas DK, Iglehart JD, Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer, J Cell Physiol 209 (2006), 645-52.
8. Curran JE, Weinstein SR, Griffiths LR, Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer, Cancer Lett 188 (2002), 103-7.
9. Cai H, Sun L, Cui L, Cao Q, Qin C, Zhang G, Mao X, Wang M, Zhang Z, Shao P, Yin C, A Functional Insertion/Deletion Polymorphism (-94ins/del ATTG) in the Promoter Region of the NFKB1 Gene Is Related to the Risk of Renal Cell Carcinoma, Urol Int (2012).
10. Loganathan R, Selvaduray KR, Nesaretnam K, Radhakrishnan AK, Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP-ribose) polymerase cleavage and inhibiting nuclear factor kappa-B activity, Cell Prolif 46 (2013), 203-13.
11. Zhou B, Qie M, Wang Y, Yan L, Zhang Z, Liang A, Wang T, Wang X, Song Y, Zhang L, Relationship between NFKB1-94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk, Ann Oncol 21 (2010), 506-11.
12. Zubair A, Frieri M, Role of nuclear factor-kB in breast and colorectal cancer, Curr Allergy Asthma Rep 13 (2013), 44-9.
13. Li P, Gu J, Yang X, Cai H, Tao J, Lu Q, Wang Z, Yin C, Gu M, Functional Promoter-94ins/del ATTG Polymorphism in NFKB1 Gene Is Associated with Bladder Cancer Risk in a Chinese Population, PLoS One 8 (2013), e71604.
14. Riemann K, Becker L, Struwe H, Rubben H, Eisenhardt A, SiffertW, Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer, Int J Clin Pharmacol Ther 45 (2007), 423-30.
15. Huo ZH, Zhong HJ, Zhu YS, Xing B, Tang H, Roles of functional NFKB1 and beta-TrCP insertion/deletion polymorphisms in mRNA expression and epithelial ovarian cancer susceptibility, Genet Mol Res 12 (2013), 3435-43.
16. Huang D, Yang L, Liu Y, Zhou Y, Guo Y, Pan M,Wang Y, Tan Y, Zhong H, Hu M, LuW, JiW,Wang J, Ran P, Zhong N, Lu J, Functional polymorphisms in NFkappaB1/IkappaBalpha predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese, Hum Genet 132 (2013), 451-60.
17. Burnik FS, Yalcin S, NFKB1-94 insertion/deletion ATTG polymorphism in gastroenteropancreatic neuroendocrine tumors, Chemotherapy 55 (2009), 381-5.
18. Martin J, Perez-Armengol C, Miranda-Filloy JA, Vilchez JR, Lopez-Nevot MA, Garcia-Porrua C, Gonzalez-Gay MA, Lack of association of a functional-94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain, J Rheumatol 33 (2006), 285-8.
19. Andersen V, Christensen J, Overvad K, Tjonneland A, Vogel U, Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes, BMC Cancer 10 (2010), 484.
20. Mohd Suzairi MS, Tan SC, Ahmad Aizat AA, Mohd Aminudin M, Siti Nurfatimah MS, Andee ZD, Ankathil R, The functional-94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer, Cancer Epidemiol 37 (2013), 634-8.
21. Lewander A, Butchi AK, Gao J, He LJ, Lindblom A, Arbman G, Carstensen J, Zhang ZY, Sun XF, Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations, Scand J Gastroenterol 42 (2007), 1332-8.
22. Kopp TI, Friis S, Christensen J, Tjonneland A, Vogel U, Polymorphisms in genes related to inflammation, NSAID use, and the risk of prostate cancer among Danish men, Cancer Genet (2013).
23. Zhang P, Wei Q, Li X, Wang K, Zeng H, Bu H, Li H, A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases susceptibility for prostate cancer, Cancer Genet Cytogenet 191 (2009), 73-7.
24. FanY,YuW, Ye P, WangH, Wang Z, Meng Q, Duan Y, Liang X, AnW, NFKB1 Insertion/Deletion Promoter Polymorphism Increases the Risk of Advanced Ovarian Cancer in a Chinese Population, DNA Cell Biol 30 (2011), 241-5.
25. Tang T, Cui S, Deng X, Gong Z, Jiang G,Wang P, Liao B, Fei Z, Xian S, Zeng D, Li J, Insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for superficial bladder cancer in Chinese, DNA Cell Biol 29 (2010), 9-12.
26. Zhou B, Rao L, Li Y, Gao L, Wang Y, Chen Y, Xue H, Song Y, Peng Y, Liao M, Zhang L, A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma, Cancer Lett 275 (2009), 72-6.
27. Lo SS, Chen JH,Wu CW, LuiWY, Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients, Surgery 145 (2009), 280-5.
28. Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW, Chang CS, Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers, Cancer Lett 243 (2006), 47-54.
29. Zou YF, Yuan FL, Feng XL, Tao JH, Ding N, Pan FM, Wang F, Association between NFKB1-94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis, Cancer Invest 29 (2011), 78-85.
30. Eskandari-Nasab E, Hashemi M, Ebrahimi M, Amininia S, Bahari G, Mashhadi MA, Taheri M, Evaluation of CCL5-403 G>A and CCR5 Delta32 gene polymorphisms in patients with breast cancer, Cancer Biomark 14 (2014), 343-51.
31. Eskandari-Nasab E, Hashemi M, Hasani SS, Omrani M, Taheri M, Mashhadi MA, Association between HLA-G 3'UTR 14-bp ins/del polymorphism and susceptibility to breast cancer, Cancer Biomark 13 (2013), 253-9.
32. Hashemi M, Eskandari-Nasab E, Fazaeli A, Rezaei H, Mashhadi MA, Arbabi F, Taheri M, Bi-directional PCR allelespecific amplification (bi-PASA) for detection of caspase-8-652 6N ins/del promoter polymorphism (rs3834129) in breast cancer, Gene 505 (2012), 176-9.
33. Hashemi M, Eskandari-Nasab E, Fazaeli A, Bahari A, Hashemzehi NA, Shafieipour S, Taheri M, Moazeni-Roodi A, Zakeri Z, Bakhshipour A, Ghavami S, Association of genetic polymorphisms of glutathione-S-transferase genes (GSTT1, GSTM1, and GSTP1) and susceptibility to nonalcoholic fatty liver disease in Zahedan, Southeast Iran, DNA Cell Biol 31 (2012), 672-7.
34. Song S, Chen D, Lu J, Liao J, Luo Y, Yang Z, Fu X, Fan X, Wei Y, Yang L, Wang L, Wang J, NFkappaB1 and NFkappaBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population, PLoS One 6 (2011), e21726.
35. Ling J, Kumar R, Crosstalk between NFkB and glucocorticoid signaling: a potential target of breast cancer therapy, Cancer Lett 322 (2012), 119-26.